1,010
Participants
Start Date
June 30, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
March 31, 2016
Clinical Trial Site, Brussels
Clinical Trial Site, Barcelona
Clinical Trial Site, Barcelona
Clinical Trial Site, Philadelphia
Clinical Trial Site, Philadelphia
Clinical Trial Site, Washington D.C.
Clinical Trial Site, Washington D.C.
Clinical Trial Site, Washington D.C.
Clinical Trial Site, Richmond
Clinical Trial Site, Richmond
Clinical Trial Site, Atlanta
Clinical Trial Site, Atlanta
Clinical Trial Site, Chicago
Clinical Trial Site, Chicago
Clinical Trial Site, Chicago
Clinical Trial Site, Los Angeles
Clinical Trial Site, Los Angeles
Clinical Trial Site, Little Rock
Clinical Trial Site, Bakersfield
Clinical Trial Site, La Mesa
Clinical Trial Site, San Francisco
Clinical Trial Site, Torrance
Clinical Trial Site, Aurora
Clinical Trial Site, Tampa
Clinical Trial Site, Athens
Clinical Trial Site, Macon
Clinical Trial Site, Merrillville
Clinical Trial Site, Baltimore
Clinical Trial Site, Boston
Clinical Trial Site, Springfield
Clinical Trial Site, Detroit
Clinical Trial Site, Jackson
Clinical Trial Site, St Louis
Clinical Trial Site, Camden
Clinical Trial Site, Rochester
Clinical Trial Site, Rosedale
Clinical Trial Site, The Bronx
Clinical Trial Site, Williamsville
Clinical Trial Site, Durham
Clinical Trial Site, Cleveland
Clinical Trial Site, Pittsburgh
Clinical Trial Site, Charleston
Clinical Trial Site, Fort Worth
Clinical Trial Site, Plano
Clinical Trial Site, Falls Church
Clinical Trial Site, Norfolk
Clinical Trial Site, Anderlecht
Clinical Trial Site, Hasselt
Clinical Trial Site, Roeselare
Clinical Trial Site, Blumenau
Clinical Trial Site, Bordeaux
Clinical Trial Site, Toulouse
Clinical Trial Site, Vandœuvre-lès-Nancy
Clinical Trial Site, Madrid
Clinical Trial Site, Seville
Clinical Trial Site, Cardiff
Clinical Trial Site, London
Clinical Trial Site, London
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY